Navigation Links
Omthera Announces Waiver of Lock-Up Restriction
Date:7/11/2013

ould be deemed forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions and uncertainties that may cause actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements, and you should not place undue reliance on these statements. Some of the factors that could cause actual results to differ materially from current expectations are: the ability to consummate the proposed transaction; any conditions imposed on the parties in connection with the consummation of the proposed transaction; the failure of the Company's stockholders to approve the proposed transaction; the ability to obtain regulatory approvals of the proposed transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the agreement relating to the proposed transaction; the Company's ability to maintain relationships with employees and third parties following announcement of the proposed transaction; the ability of the parties to satisfy the conditions to the closing of the proposed transaction; the risk that the proposed transaction may not be completed in the time frame expected by the parties or at all; and the risks that are described from time to time in the Company's reports filed with the SEC, including the Prospectus, in other of the Company's filings with the SEC from time to time, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and on general industry and economic conditions. If the proposed transaction is consummated, our stockholders will cease to have any equity interest in the Company and will have no right to participate in its earnings and future growth. The Company disclaims any intention or obligation to update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

Omthera Contact: 
Christian Schade
Ex
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
2. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
3. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
4. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
5. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
6. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
7. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
8. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
11. UM Ventures Announces Collaboration Between UM School Of Medicines Dr. Frank Robb and Fina Biosolutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Pa. , April 1, 2015  Pittman ... the introduction of PLG24, PLG42K, PLG42S, PLG52, and ... with Pittman brush and brushless DC motors and ... The new products add 35 standard motor-gearbox family ... PLG planetary gearboxes deliver high torque loads with ...
(Date:4/1/2015)... and MOUNTAIN VIEW, Calif. ... (NYSE: BSX ) announces that it has ... a venture-backed medical device company that develops, manufactures ... (EUS) guided transluminal drainage of targeted areas within ... close this week. The Xlumena ...
(Date:4/1/2015)... ASPEN, Colo. , April 1, 2015 /PRNewswire/ ... Foundation (CKF), is pleased to sponsor the second annual ... the award, which will recognize two transplant recipients who ... is a career accomplishment, participation in a sport or ... and loved ones. "The Bounce Back ...
Breaking Medicine Technology:Pittman Motors Expands PLG Planetary Gearbox Offering 2Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3
... Sept. 21 The Association of Medical Media (AMM) ... highest-scoring medical journal advertisements Thursday, September 16, 2010.   ... annual study developed by AMM, researches physician attitudes toward ... 21 specialties from the 86 most widely-advertised products in ...
... More than one in three diabetes patients skip doses ... they have done so on average three times in the ... reality this number could be as high as six doses*, ... Insulin Therapy (GAPP™) survey, released today by Novo Nordisk. ...
Cached Medicine Technology:AMM Names 2010 Doctors' Choice Awards Winners 2AMM Names 2010 Doctors' Choice Awards Winners 3New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 2New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 3
(Date:4/1/2015)... EAGAN, Minn. (April 1, 2015) —Blue Cross and ... (Blue Cross) today announced audited financial results for 2014. ... of $61.5 million, reflecting positive investment portfolio performance that ... operating loss of $8.2 million on full-year revenues of ... of one percent (0.1%). , Blue Cross reported ...
(Date:4/1/2015)... 2015 Dr Roz Kamani, a Vancouver ... now offering her patients an opportunity to learn more ... in “Beauty Days”, which is an exclusive VIP event ... Kitsilano Skin Care Clinic. It is attended by Dr ... the latest products and services that are on offer. ...
(Date:4/1/2015)... Ill. (PRWEB) April 01, 2015 OSF ... OSF Healthcare System , was welcomed into the ... Ceremony officiated by Msgr. Paul E. Showalter, vicar general ... The Blessing and Dedication culminated a nearly year-long transition ... eleventh OSF HealthCare hospital. Speakers for the morning ceremony ...
(Date:4/1/2015)... 01, 2015 Like a mosaic slowly ... scientific understanding of the potential causes of rosacea. April ... National Rosacea Society (NRS) to educate the public on ... disorder now estimated to affect more than 16 million ... research on rosacea through its patient-funded research grants program, ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 eMindful ... the expansion of its executive team with the addition ... digital officer. , In his new role, ... and user interface across the business and consumer portals. ... and building the company’s online community. His hiring ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3
... just one of two gene copies inherited from either parent. ... from one parent, called a "hemizygous" deletion, can contribute to ... a professor in the Department of Genetics at Harvard Medical ... an answer. The most common hemizygous deletions in cancer, their ...
... UC Irvine immunologist will receive $4.8 million to create a ... to treat multiple sclerosis. The California Institute for Regenerative ... of the Sue & Bill Gross Stem Cell Research Center ... board gave 21 such grants worth $69 million to 11 ...
... is involved in removing beta-amyloid, the main Alzheimer,s-causing substance in ... that this may apply in humans. Researchers at ... with colleagues in the National Institute on Aging in the ... of genes in blood samples from nearly 700 people. The ...
... coated with colloidal silver, which prevents the growth of ... the filter. Other metals such as copper and zinc ... from Princeton University in New Jersey used atomic force ... Escherichia coli ( E. coli ) bacteria ...
... Feola, a University of Kentucky College of Pharmacy faculty ... received a five-year, $1.8 million grant from the National ... immune responses in the lungs that will potentially lead ... cystic fibrosis and other chronic pulmonary inflammatory conditions. ...
... , THURSDAY, May 24 (HealthDay News) -- Morbidly obese patients ... of developing complications and also face higher hospital costs, a ... common operation for spinal pain. People with a body mass ... obese. They are generally 50 to 100 percent over their ...
Cached Medicine News:Health News:Cancer may require simpler genetic mutations than previously thought 2Health News:Cancer may require simpler genetic mutations than previously thought 3Health News:UCI stem cell researcher to receive $4.8 million in state funding 2Health News:Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis 2Health News:Severely Obese Have More Complications With Spinal Surgery 2
Gynecomastia Vest...
Male Compression Vest, Front Closure...
Female Mini-VEST, Front Closure, X-Firm...
For Lipoplasty or surgery of abdomen, flanks and midriff...
Medicine Products: